[English] 日本語
Yorodumi- EMDB-52411: Inward-open structure of human glycine transporter 2 in substrate... -
+
Open data
-
Basic information
| Entry | ![]() | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Inward-open structure of human glycine transporter 2 in substrate-free state | ||||||||||||
Map data | Substrate-free GlyT2, Final map | ||||||||||||
Sample |
| ||||||||||||
Keywords | Transport protein / SLC6A5 / neurotransmitter/sodium symporter / Sodium- and chloride-dependent glycine transporter 2 / MEMBRANE PROTEIN | ||||||||||||
| Function / homology | Function and homology informationDefective SLC6A5 causes hyperekplexia 3 (HKPX3) / glycine:sodium symporter activity / synaptic transmission, glycinergic / glycine import across plasma membrane / dense core granule / SLC-mediated transport of neurotransmitters / neurotransmitter transport / sodium ion transmembrane transport / chemical synaptic transmission / endosome ...Defective SLC6A5 causes hyperekplexia 3 (HKPX3) / glycine:sodium symporter activity / synaptic transmission, glycinergic / glycine import across plasma membrane / dense core granule / SLC-mediated transport of neurotransmitters / neurotransmitter transport / sodium ion transmembrane transport / chemical synaptic transmission / endosome / synapse / metal ion binding / membrane / plasma membrane Similarity search - Function | ||||||||||||
| Biological species | Homo sapiens (human) | ||||||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.97 Å | ||||||||||||
Authors | Cantwell Chater RP / Peiser-Oliver J / Pati TK / Quinn AS / Lotsaris I / Frangos ZJ / Anderson KE / Tischer AE / Williams-Noonan BJ / Aubrey KR ...Cantwell Chater RP / Peiser-Oliver J / Pati TK / Quinn AS / Lotsaris I / Frangos ZJ / Anderson KE / Tischer AE / Williams-Noonan BJ / Aubrey KR / O Mara ML / Michaelides M / Mohammadi SA / Cioffi CL / Vandenberg RJ / Shahsavar A | ||||||||||||
| Funding support | Denmark, United States, 3 items
| ||||||||||||
Citation | Journal: Nat Commun / Year: 2026Title: A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects. Authors: Ryan P Cantwell Chater / Julian Peiser-Oliver / Tanmay K Pati / Ada S Quinn / Irina Lotsaris / Zachary J Frangos / Kristen E Anderson / Anna E Tischer / Billy J Williams-Noonan / Karin R ...Authors: Ryan P Cantwell Chater / Julian Peiser-Oliver / Tanmay K Pati / Ada S Quinn / Irina Lotsaris / Zachary J Frangos / Kristen E Anderson / Anna E Tischer / Billy J Williams-Noonan / Karin R Aubrey / Megan L O'Mara / Michael Michaelides / Sarasa A Mohammadi / Christopher L Cioffi / Robert J Vandenberg / Azadeh Shahsavar / ![]() Abstract: Chronic neuropathic pain, caused by nerve damage or disease, is increasing in prevalence, but current treatments are ineffective and over-reliant on opioids. The neuronal glycine transporter, GlyT2, ...Chronic neuropathic pain, caused by nerve damage or disease, is increasing in prevalence, but current treatments are ineffective and over-reliant on opioids. The neuronal glycine transporter, GlyT2, regulates inhibitory glycinergic neurotransmission and represents a promising target for new analgesics. However, most GlyT2 inhibitors cause significant side effects, in part due to irreversible inhibition at analgesic doses. Here we develop a reversible inhibitor of GlyT2, RPI-GLYT2-82, and identify its binding site by determining cryo-EM structures of human GlyT2. We capture three fundamental conformational states of GlyT2 in the substrate-free state, and bound to either glycine, RPI-GLYT2-82 or the pseudo-irreversible inhibitor ORG25543. We demonstrate that RPI-GLYT2-82 dissociates from GlyT2 faster than ORG25543, providing analgesia in mouse neuropathic pain models without on-target side-effects or addiction liability. Our data provide a mechanistic understanding of allosteric inhibition of glycine transport, enabling structure-based design of non-opioid analgesics. | ||||||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_52411.map.gz | 97.1 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-52411-v30.xml emd-52411.xml | 21.6 KB 21.6 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_52411_fsc.xml | 9.9 KB | Display | FSC data file |
| Images | emd_52411.png | 66.4 KB | ||
| Filedesc metadata | emd-52411.cif.gz | 6.8 KB | ||
| Others | emd_52411_half_map_1.map.gz emd_52411_half_map_2.map.gz | 95.7 MB 95.7 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-52411 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-52411 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9hugMC ![]() 9hueC ![]() 9hufC ![]() 9r1hC C: citing same article ( M: atomic model generated by this map |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_52411.map.gz / Format: CCP4 / Size: 103 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Substrate-free GlyT2, Final map | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.728 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: half map B
| File | emd_52411_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | half_map_B | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: half map A
| File | emd_52411_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | half_map_A | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Human glycine transporter GlyT2 in substrate-free state
| Entire | Name: Human glycine transporter GlyT2 in substrate-free state |
|---|---|
| Components |
|
-Supramolecule #1: Human glycine transporter GlyT2 in substrate-free state
| Supramolecule | Name: Human glycine transporter GlyT2 in substrate-free state type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: Sodium- and chloride-dependent glycine transporter 2
| Macromolecule | Name: Sodium- and chloride-dependent glycine transporter 2 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 68.976023 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MDENKARGNW SSKLDFILSM VGYAVGLGNV WRFPYLAFQN GGGAFLIPYL MMLALAGLPI FFLEVSLGQF ASQGPVSVWK AIPALQGCG IAMLIISVLI AIYYNVIICY TLFYLFASFV SVLPWGSCNN PWNTPECKDK TKLLLDSCVI SDHPKIQIKN S TFCMTAYP ...String: MDENKARGNW SSKLDFILSM VGYAVGLGNV WRFPYLAFQN GGGAFLIPYL MMLALAGLPI FFLEVSLGQF ASQGPVSVWK AIPALQGCG IAMLIISVLI AIYYNVIICY TLFYLFASFV SVLPWGSCNN PWNTPECKDK TKLLLDSCVI SDHPKIQIKN S TFCMTAYP NVTMVNFTSQ ANKTFVSGSE EYFKYFVLKI SAGIEYPGEI RWPLALCLFL AWVIVYASLA KGIKTSGKVV YF TATFPYV VLVILLIRGV TLPGAGAGIW YFITPKWEKL TDATVWKDAA TQIFFSLSAA WGGLITLSSY NKFHNNCYRD TLI VTCTNS ATSIFAGFVI FSVIGFMANE RKVNIENVAD QGPGIAFVVY PEALTRLPLS PFWAIIFFLM LLTLGLDTMF ATIE TIVTS ISDEFPKYLR THKPVFTLGC CICFFIMGFP MITQGGIYMF QLVDTYAASY ALVIIAIFEL VGISYVYGLQ RFCED IEMM IGFQPNIFWK VCWAFVTPTI LTFILCFSFY QWEPMTYGSY RYPNWSMVLG WLMLACSVIW IPIMFVIKMH LAPGRF IER LKLVCSPQPD WGPFLAQHRG ERYKNMIDPL GTSSLGLKLP VKDLELGTQC UniProtKB: Sodium- and chloride-dependent glycine transporter 2 |
-Macromolecule #2: CHOLESTEROL
| Macromolecule | Name: CHOLESTEROL / type: ligand / ID: 2 / Number of copies: 2 / Formula: CLR |
|---|---|
| Molecular weight | Theoretical: 386.654 Da |
| Chemical component information | ![]() ChemComp-CLR: |
-Macromolecule #3: CHLORIDE ION
| Macromolecule | Name: CHLORIDE ION / type: ligand / ID: 3 / Number of copies: 1 / Formula: CL |
|---|---|
| Molecular weight | Theoretical: 35.453 Da |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 7.5 |
|---|---|
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277.15 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Specialist optics | Energy filter - Name: TFS Selectris X / Energy filter - Slit width: 10 eV |
| Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Number grids imaged: 1 / Number real images: 21335 / Average exposure time: 3.34 sec. / Average electron dose: 60.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 1.8 µm / Nominal defocus min: 0.6 µm / Nominal magnification: 165000 |
| Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
Denmark,
United States, 3 items
Citation










Z (Sec.)
Y (Row.)
X (Col.)





































Processing
FIELD EMISSION GUN


